Chi KN - Search Results

1

Efficacy of enzalutamide following abiraterone acetate in chemotherapy-naive metastatic castration-resistant prostate cancer patients.

Azad AA, Eigl BJ, Murray RN, Kollmannsberger C, Chi KN. Azad AA, et al. Among authors: chi kn. Eur Urol. 2015 Jan;67(1):23-29. doi: 10.1016/j.eururo.2014.06.045. Epub 2014 Jul 10. Eur Urol. 2015. PMID: 25018038

2

Asian race and impact on outcomes after radical radiotherapy for localized prostate cancer.

Man A, Pickles T, Chi KN; British Columbia Cancer Agency Prostate Cohort Outcomes Initiative. Man A, et al. Among authors: chi kn. J Urol. 2003 Sep;170(3):901-4. doi: 10.1097/01.ju.0000081423.37043.b4. J Urol. 2003. PMID: 12913726

3

Targeting Bcl-2 with oblimersen for patients with hormone refractory prostate cancer.

Chi KN. Chi KN. World J Urol. 2005 Feb;23(1):33-7. doi: 10.1007/s00345-004-0477-x. Epub 2005 Feb 19. World J Urol. 2005. PMID: 15723221 Review.

4

Timing is everything: preclinical evidence supporting simultaneous rather than sequential chemohormonal therapy for prostate cancer.

Eigl BJ, Eggener SE, Baybik J, Ettinger S, Chi KN, Nelson C, Wang Z, Gleave ME. Eigl BJ, et al. Among authors: chi kn. Clin Cancer Res. 2005 Jul 1;11(13):4905-11. doi: 10.1158/1078-0432.CCR-04-2140. Clin Cancer Res. 2005. PMID: 16000589 Free article.

5

Minimizing treatment without compromising cure with primary surveillance for clinical stage I embryonal predominant nonseminomatous testicular cancer: a population based analysis from British Columbia.

Al-Tourah AJ, Murray N, Coppin C, Kollmannsberger C, Man A, Chi KN. Al-Tourah AJ, et al. Among authors: chi kn. J Urol. 2005 Dec;174(6):2209-13, discussion 2213. doi: 10.1097/01.ju.0000181810.22617.f8. J Urol. 2005. PMID: 16280765

6

A phase I dose finding study of cisplatin, gemcitabine, and weekly docetaxel for patients with advanced transitional cell cancer.

Tinker A, Winquist E, Canil C, Moore M, Murray RN, Chi KN. Tinker A, et al. Among authors: chi kn. Am J Clin Oncol. 2006 Feb;29(1):3-7. doi: 10.1097/01.coc.0000200044.81711.57. Am J Clin Oncol. 2006. PMID: 16462494 Clinical Trial.

7

Prednisone monotherapy in asymptomatic hormone refractory prostate cancer.

Heng DY, Chi KN. Heng DY, et al. Among authors: chi kn. Can J Urol. 2006 Dec;13(6):3335-9. Can J Urol. 2006. PMID: 17187697

8

Intermittent chemotherapy in patients with metastatic androgen-independent prostate cancer: results from ASCENT, a double-blinded, randomized comparison of high-dose calcitriol plus docetaxel with placebo plus docetaxel.

Beer TM, Ryan CW, Venner PM, Petrylak DP, Chatta GS, Ruether JD, Chi KN, Young J, Henner WD; ASCENT(AIPC Study of Calcitriol ENhancing Taxotere) Investigators. Beer TM, et al. Among authors: chi kn. Cancer. 2008 Jan 15;112(2):326-30. doi: 10.1002/cncr.23163. Cancer. 2008. PMID: 17960793 Free article. Clinical Trial.

9

Multicenter phase II study of combined neoadjuvant docetaxel and hormone therapy before radical prostatectomy for patients with high risk localized prostate cancer.

Chi KN, Chin JL, Winquist E, Klotz L, Saad F, Gleave ME. Chi KN, et al. J Urol. 2008 Aug;180(2):565-70; discussion 570. doi: 10.1016/j.juro.2008.04.012. Epub 2008 Jun 12. J Urol. 2008. PMID: 18554663 Clinical Trial.

10

Systemic therapy after first-line docetaxel in metastatic castration-resistant prostate cancer.

Beardsley EK, Chi KN. Beardsley EK, et al. Among authors: chi kn. Curr Opin Support Palliat Care. 2008 Sep;2(3):161-6. doi: 10.1097/SPC.0b013e32830c48a3. Curr Opin Support Palliat Care. 2008. PMID: 18685415 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

283 results

Search Page

Filters